Newstral
Article
Mmvtelegraph.com on 2021-03-19 08:07
India Covid-19 vaccination marketing campaign, weighs the director of the Serum Institute
Related news
- MSerum Institute for Prioritizing Indiamvtelegraph.com
- Coronavirus | Serum Institute of India stocking emergency doses of COVID-19 vaccineThe Hindu
- KVaccines And Vaccination Market 2021 Watch How Big Rising Opportunities To Set Epic Growth Till 2027 | Serum Institute of India Pvt. Ltd., Pfizer, Johnson & Johnson, AstraZenecea plc & Moreksusentinel.com
- Never exported vaccines at the cost of people of India, says Serum Institute of IndiaThe Hindu
- Serum Institute of India to focus on supplying COVID-19 vaccine to India firstThe Hindu
- 5 dead after major fire hits Serum Institute of India plant in PuneThe Hindu
- COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR, Serum Institute of IndiaThe Hindu
- Coronavirus | Serum Institute seeks emergency use nod for Covishield in IndiaThe Hindu
- Serum Institute of India set to invest £240 million in U.K.The Hindu
- MHow this Millennial CEO ran the Serum Institute of India throughout Covidmvtelegraph.com
- Serum Institute gets DCGI nod to make Sputnik V in IndiaThe Hindu
- Oxford vaccine: DCGI directs Serum Institute of India to suspend recruitment for trialsThe Hindu
- Serum Institute Of India Acquires 50 Percent Stake In Pharma Packaging Firm Schott Kaishatntribune.com
- Serum Institute puts India trials of Oxford's Covid vaccine on holdThe Times of India
- Serum Institute of India could resume vaccine exports by June if local coronavirus cases subsideSouth China Morning Post
- No new govt order, Covishield output to be cut by 50%: Serum Institute of IndiaThe Times of India
- Coronavirus | Government likely to grant ₹30 bn to Serum Institute of IndiaThe Hindu
- Coronavirus live updates | After Pfizer, Serum Institute seeks emergency use nod for Covishield in IndiaThe Hindu
- Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 VaccinesForbes
- Serum Institute seeks indemnity from liability: sourcesThe Hindu